María
Currás Freixes
Forscherin bis um 2022
Hospital Universitario 12 de Octubre
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (7)
2023
-
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Nature Communications, Vol. 14, Núm. 1
2021
2019
-
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma
Theranostics, Vol. 9, Núm. 17, pp. 4946-4958
2018
-
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients
Genetics in Medicine, Vol. 20, Núm. 12, pp. 1652-1662
2017
-
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588
2015
-
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Journal of Medical Genetics, Vol. 52, Núm. 10, pp. 647-656
-
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene
Journal of the National Cancer Institute, Vol. 107, Núm. 5